Analgesic purchases among older adults – a population-based study

BMC Public Health

Table 4 Associated factors in opioid-purchasing participants with no SF-36 pain. A multivariate logistic regression model

	No SF-36 pain intensity N = 74		No SF-36 pain-related interference N = 138
	OR (95% CI)	p-value	OR (95% CI)	p-value
Male sex	0.88 (0.47 to 1.63)	0.68	1.20 (0.78 to 1.86)	0.40
Age	0.99 (0.94 to 1.03)	0.58	0.97 (0.94 to 1.01)	0.095
Education years	1.01 (0.92 to 1.10)	0.88	1.03 (0.97 to 1.09)	0.37
Smoking	1.71 (0.77 to 3.80)	0.19	1.08 (0.62 to 1.90)	0.78
AUDIT-C^a	0.95 (0.82 to 1.10)	0.47	0.97 (0.88 to 1.08)	0.62
LTPA^b		0.99		0.64
Low	1 (Reference)		1 (Reference)
Moderate	0.99 (0.43 to 2.32)		0.92 (0.50 to 1.69)
High	1.00 (0.34 to 2.87)		0.83 (0.39 to 1.79)
MetS^c	1.99 (1.10 to 3.60)	0.022*	1.60 (1.05 to 2.43)	0.029*
Number of morbidities^d	1.84 (1.17 to 2.90)	0.008*	1.50 (1.08 to 2.07)	0.015*

*P-values less than 0.05 were considered statistically significant. ^aAUDIT-C Alcohol unit consumption per week, ^bLTPA Leisure-time physical activity, ^cMetS Metabolic syndrome, ^dNumber of morbidities sum of each participant’s diagnosed morbidities. Comparison to subjects that had received opioid prescription and reported some pain 1) intensity for ‘No pain intensity’ 2) interference for ‘No pain interference’

ISSN: 1471-2458